P. O'Grady

Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.

K. F. Yee, S. Sclarovsky, R. Greenbaum, 2000, British journal of clinical pharmacology.

Quinolizidine Derivatives. A Study of the Reductive Cyclization of Some γ-(2-Pyridyl)-butyronitriles

V. Boekelheide, P. O'Grady, M. Lamborg, 1953 .

Capillary electrophoretic determination of oxalate in amniotic fluid

S. Wise, B. Nelson, P. O'Grady, 2000 .

Fosinopril/hydrochlorothiazide: single dose and steady-state pharmacokinetics and pharmacodynamics.

K. F. Yee, R. Lins, B. Mangold, 1999, British Journal of Clinical Pharmacology.

Modified lamellar body phospholipid assay compared with L/S ratio and phosphatidylglycerol assay for assessment of fetal pulmonary status.

J. Reynolds, J. Swanson, M. Novy, 1987, Clinical chemistry.

Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5‐HT3 Antagonist, in Cancer Patients Treated with Cisplatin

T. Conroy, G. Prévot, M. Spielmann, 1994, American journal of clinical oncology.

A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapy.

Y. Merrouche, P. Rebattu, J. Guastalla, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Early clinical trial of MDL 73.147 EF: a new 5-HT3-receptors antagonist for the prevention of chemotherapy-induced nausea and vomiting.

M. Aapro, M. Boyce, P. Alberto, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Recurrent life-threatening thrombocytopenia in a patient with chronic "Parstelin" dependence.

P. O'Grady, P. A. Carney, 1997, Irish medical journal.